1. Home
  2. VREX vs BCYC Comparison

VREX vs BCYC Comparison

Compare VREX & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$13.93

Market Cap

483.7M

Sector

Technology

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$6.52

Market Cap

476.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
BCYC
Founded
2016
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.7M
476.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
VREX
BCYC
Price
$13.93
$6.52
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$16.67
$18.73
AVG Volume (30 Days)
300.0K
247.3K
Earning Date
02-05-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$844,600,000.00
$28,339,000.00
Revenue This Year
$4.79
N/A
Revenue Next Year
$4.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.14
N/A
52 Week Low
$6.76
$6.03
52 Week High
$15.46
$14.95

Technical Indicators

Market Signals
Indicator
VREX
BCYC
Relative Strength Index (RSI) 75.49 43.09
Support Level $13.02 $6.37
Resistance Level $13.99 $6.88
Average True Range (ATR) 0.51 0.32
MACD 0.15 -0.02
Stochastic Oscillator 95.22 23.63

Price Performance

Historical Comparison
VREX
BCYC

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: